The Association between Serum Uric Acid and Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus: A Multicenter Nationwide Cross- Sectional Study
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: The role of uric acid in the development of diabetic peripheral neuropathy remains unclear. This study aimed to determine the association between uric acid and peripheral neuropathy among type 2 diabetes mellitus (T2DM) patients. Methods: We conducted a nationwide cross-sectional study based on the diabetes and hypertension study of the Medical Research Network of the Consortium of Thai Medical Schools. Adult T2DM patients from 831 public hospitals in Thailand were evaluated. The serum uric acid level was categorized into five groups based on quintiles (<4.4, 4.4–5.3, 5.3–6.2, 6.2–7.3, and >7.3 mg/dL). A multivariate logistic regression model was used to assess the independent association between serum uric acid level and peripheral neuropathy. Results: In total, 7,511 T2DM patients with available data about serum uric acid levels were included in the analysis. The mean age of the participants was 61.7±10.9 years, and approximately 35.6% were men. The prevalence rate of peripheral neuropathy was 3.0%. Moreover, the prevalence rates of peripheral neuropathy stratified according to uric acid levels <4.4, 4.4–5.3, 5.3–6.2, 6.2–7.3, and >7.3 mg/dL were 2.5%, 2.8%, 2.4%, 2.5%, and 4.7%, respectively. A serum uric acid level ≥7.3 mg/dL was found to be associated with an increase in odds ratio (1.54; 95% confidence interval, 1.02–2.32) for peripheral neuropathy compared with a serum uric acid level <4.4 mg/dL. Conclusion: Serum uric acid level is independently associated with peripheral neuropathy in T2DM patients, and elevated serum uric acid levels should be considered a risk factor for diabetic peripheral neuropathy in clinical practice.
Abstract
Background: The role of uric acid in the development of diabetic peripheral neuropathy remains unclear. This study aimed to determine the association between uric acid and peripheral neuropathy among type 2 diabetes mellitus (T2DM) patients. Methods: We conducted a nationwide cross-sectional study based on the diabetes and hypertension study of the Medical Research Network of the Consortium of Thai Medical Schools. Adult T2DM patients from 831 public hospitals in Thailand were evaluated. The serum uric acid level was categorized into five groups based on quintiles (<4.4, 4.4–5.3, 5.3–6.2, 6.2–7.3, and >7.3 mg/dL). A multivariate logistic regression model was used to assess the independent association between serum uric acid level and peripheral neuropathy. Results: In total, 7,511 T2DM patients with available data about serum uric acid levels were included in the analysis. The mean age of the participants was 61.7±10.9 years, and approximately 35.6% were men. The prevalence rate of peripheral neuropathy was 3.0%. Moreover, the prevalence rates of peripheral neuropathy stratified according to uric acid levels <4.4, 4.4–5.3, 5.3–6.2, 6.2–7.3, and >7.3 mg/dL were 2.5%, 2.8%, 2.4%, 2.5%, and 4.7%, respectively. A serum uric acid level ≥7.3 mg/dL was found to be associated with an increase in odds ratio (1.54; 95% confidence interval, 1.02–2.32) for peripheral neuropathy compared with a serum uric acid level <4.4 mg/dL. Conclusion: Serum uric acid level is independently associated with peripheral neuropathy in T2DM patients, and elevated serum uric acid levels should be considered a risk factor for diabetic peripheral neuropathy in clinical practice.
참고문헌 (30)
- Rowley WR, "Diabetes 2030 : insights from yesterday, today, and future trends", Popul Health Manag, 20, pp.6~12 (2017)
- Waldfogel JM, "Pharmacotherapy for diabetic peripheral neuropathy pain and quality of life : a systematic review", Neurology, 88, pp.1958~1967 (2017)
- Pop-Busui R, "Diabetic neuropathy : a position statement by the American Diabetes Association", Diabetes Care, 40, pp.136~154 (2017)
- Barrett EJ, "Diabetic microvascular disease : an endocrine society scientific statement", J Clin Endocrinol Metab, 102, pp.4343~4410 (2017)
- Feldman EL, "New horizons in diabetic neuropathy : mechanisms, bioenergetics, and pain", Neuron, 93, pp.1296~1313 (2017)
- Trnkova L, "Oxidation as an important factor of protein damage : implications for Maillard reaction", J Biosci, 40, pp.419~439 (2015)
- Kanbay M, "The role of uric acid in the pathogenesis of human cardiovascular disease", Heart, 99, pp.759~766 (2013)
- Puddu P, "Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease : molecular mechanisms and clinical implications", J Cardiol, 59, pp.235~242 (2012)
- "Data Archival for Maximum Utilization System (DAMUS): DM/HT study (NHSO Research Project)" (2014)[URL]
- Diabetes Association of Thailand, "Clinical practice guideline for diabetes 2011(Thai version)", Srimuang Printing Company Limited, ~ (2011)
- Levey AS, "A new equation to estimate glomerular filtration rate", Ann Intern Med, 150, pp.604~612 (2009)
- Dyck PJ, "Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy", Diabetes Care, 10, pp.432~440 (1987)
- Chalermsri C, "The effectiveness of holistic diabetic management between Siriraj Continuity of Care Clinic and medical out-patient department", J Med Assoc Thai, 97(Suppl 3), pp.S197~S205 (2014)
- Kaewput W, "The association between renal function and neurological diseases in type 2 diabetes: a multicenter nationwide cross-sectional study", Hosp Pract, 47, pp.46~52 (2019)
- Davies M, "The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes", Diabetes Care, 29, pp.1518~1522 (2006)
- Abbott CA, "Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U. K", Diabetes Care, 34, pp.2220~2224 (2011)
- Nitiyanant W, "A survey study on diabetes management and complication status in primary care setting in Thailand", J Med Assoc Thai, 90, pp.65~71 (2007)
- Tesfaye S, "Vascular risk factors and diabetic neuropathy", N Engl J Med, 352, pp.341~350 (2005)
- Yagihashi S, "Mechanism of diabetic neuropathy: where are we now and where to go?", J Diabetes Investig, 2, pp.18~32 (2011)
- Sautin YY, "Uric acid : the oxidant-antioxidant paradox", Nucleosides Nucleotides Nucleic Acids, 27, pp.608~619 (2008)
- Johnson RJ, "Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?", Hypertension, 41, pp.1183~1190 (2003)
- Choi YJ, "Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis", FASEB J, 28, pp.3197~3204 (2014)
- Yu S, "Serum uric acid levels and diabetic peripheral neuropathy in type 2 diabetes : a systematic review and meta-analysis", Mol Neurobiol, 53, pp.1045~1051 (2016)
- Abraham A, "Uric acid levels correlate with the severity of diabetic sensorimotor polyneuropathy", J Neurol Sci, 379, pp.94~98 (2017)
- Lin X, "Correlation between serum uric acid and diabetic peripheral neuropathy in T2DM patients", J Neurol Sci, 385, pp.78~82 (2018)
- Papanas N, "Increased serum levels of uric acid are associated with sudomotor dysfunction in subjects with type 2 diabetes mellitus", Exp Diabetes Res, 2011, pp.346051~ (2011)
- Suzuki S, "Gender-specific relationship between serum uric acid level and atrial fibrillation prevalence", Circ J, 76, pp.607~611 (2012)
- Zhang W, "Plasma uric acid and hypertension in a Chinese community : prospective study and metaanalysis", Clin Chem, 55, pp.2026~2034 (2009)
- Weiner DE, "Uric acid and incident kidney disease in the community", J Am Soc Nephrol, 19, pp.1204~1211 (2008)
- Jin HY, "The impact of glycemic variability on diabetic peripheral neuropathy", Endocrine, 53, pp.643~648 (2016)